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Abstract
Background: G protein-coupled receptors (GPCRs) are ubiquitous surface proteins mediating various biological
responses and thus, important targets for therapeutic drugs. GPCRs individually produce their own signaling as well
as modulate the signaling of other GPCRs. Real-time observation of GPCR signaling and modulation in living cells is
key to molecular study of biological responses and pharmaceutical development. However, fluorescence imaging,
the technique widely used for this purpose, requires a fluorescent dye which may inhibit biological responses or a
fluorescent-tagged target protein created through time-consuming genetic manipulation. In this study, we applied
two-dimensional surface plasmon resonance (SPR) imaging to monitoring the translocation of protein kinase C
(PKC), a major GPCR-coupled signaling molecule in the widely used HEK293 cell lines and examined whether the
signaling of, and, modulation between heterologously expressed GPCRs can be measured without fluorescent
labeling.
Results: We cultured HEK293 cells on the gold-plated slide glass and evoked SPR at the interface between the cell’s
plasma membrane and the gold surface with incident light. The translocation of activated native PKC to the plasma
membrane is expected to alter the incident angle-SPR extent relation, and this could be detected as a change in
the intensity of light reflection from the specimen illuminated at a fixed incident angle. Direct activation of PKC
with 12-O-tetradecanoylphorbol-13-acetate increased the reflection intensity. This increase indeed reported PKC
translocation because it was reduced by a pre-treatment with bisindolylmaleimide-1, a PKC inhibitor. We further
applied this technique to a stable HEK293 cell line heterologously expressing the GPCRs type-1 metabotropic
glutamate receptor (mGluR1) and adenosine A1 receptor (A1R). (RS)-3,5-dihydroxyphenylglycine, a mGluR1 agonist,
increased the reflection intensity, and the PKC inhibitor reduced this increase. A pre-treatment with (R)-N6-
phenylisopropyladenosine, an A1R-selective agonist suppressed mGluR1-mediated reflection increase. These results
suggest that our technique can detect PKC translocation initiated by ligand binding to mGluR1 and its modulation
by A1R.
Conclusions: SPR imaging turned out to be utilizable for monitoring GPCR-mediated PKC translocation and its
modulation by a different GPCR in a heterologous expression system. This technique provides a powerful yet
easy-to-use tool for molecular study of biological responses and pharmaceutical development.
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expression, Neuron, Synaptic plasticity
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Background
G protein-coupled receptors (GPCRs) constitute a
large protein superfamily with more than 1000 candi-
date genes in the human genome [1]. GPCRs mediate
various biological responses and thus, are important
targets for therapeutic drugs. Most GPCRs can
produce intracellular signaling as monomers or homo-
meric oligomers. Moreover, many GPCRs form het-
eromeric complexes with different types of GPCRs
and produce intriguing signaling through inter-GPCR
modulation [2, 3]. Real-time observation of GPCR sig-
naling and inter-GPCR modulation in living cells is
key to molecular study of biological responses and
pharmaceutical development (e.g., ref. [4]). However,
fluorescence imaging, the technique widely used for
this purpose, requires a fluorescent dye which may
inhibit biological responses (e.g., ref. [5]) or a
fluorescent-tagged target protein created through
time-consuming genetic manipulation (e.g., ref. [6]).
Two-dimensional surface plasmon resonance (SPR)
imaging may provide a ready-to-use tool to explore
GPCR signaling and modulation in intact cells. Since
pioneered by Liedberg et al., SPR imaging has been
utilized for cell-free immunoassay to detect a specific
protein in a sample solution [7, 8]. Typically, a sam-
ple solution is examined on a gold-plated slide glass
with an antibody on its surface. Incident light given
to the slide glass evokes the resonant oscillation of
conduction electrons at the interface between the
sample solution and the gold surface (SPR) (cf.
Fig. 1b). When the target protein is trapped by the
antibody on the gold surface, the relation of the angle
of incidence to SPR extent (so-called SPR curve) will
alter. With a fixed angle of incidence, such an alter-
ation results in a decrease or increase of the con-
sumption of the incident light energy for evoking SPR
and an increase or decrease of the light reflection
from the specimens, respectively. Thus, the light re-
flection intensity can be taken as a measure of the
amount of the trapped protein. Recently, Hide’s group
[9] and Shinohara’s group [10] revealed that the accu-
mulation of intracellular proteins near the plasma
membrane of the cells cultured on a gold-plated slide
glass can also affect the SPR curve (Fig. 1a, b). The
latter group further used SPR imaging to detect trans-
location of native protein kinase C (PKC) in response
to 12-O-tetradecanoylphorbol-13-acetate (TPA), a
PKC agonist, or an agonist for native PKC-coupled
GPCR in PC12 cells [10, 11]. When activated,
conventional-type PKC is known to translocate from the
cytosol to the plasma membrane (e.g., ref. [12]) and the re-
sultant accumulation of PKC near the plasma membrane
is thought to increase the reflection [11]. PKC transloca-
tion can be taken as a measure of PKC activity. Besides,
PKC translocation itself is an important step of biological
responses because the target proteins of PKC-mediated
phosphorylation such as ionotropic glutamate receptor






























Fig. 1 Experimental set-up. a HEK293 cells were cultured on a
50 nm-thick gold-plated slide glass. The cell chamber was
surrounded with a silicone rubber wall attached to the slide glass. b
Configuration of SPR imaging. SPR takes place, consuming the
energy of the evanescent light derived from the P-polarized
component of the incident light. PKC accumulated on the plasma
membrane alters the mode of SPR, and this results in changes in the
consumption of the evanescent light energy and the intensity of the
reflection of the P-polarized light. Theta, angle of incidence. c
Sample plots of RP/S against the angle of incidence (average of 5
ROIs) before and after a 15-min application of the potent PKC
activator TPA (100 nM)
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If PKC translocation monitoring with SPR imaging is
applicable to heterologous expression systems, it will be
of great benefit to biological researchers and drug devel-
opers. In such a system, one can analyze the functions of
specific GPCR signaling cascades of interest in a reduced
cellular environment free from other signaling cascades.
In this study, we explored this possibility in the widely
used heterologous expression system based on human
embryo kidney-derived HEK293 cell lines. We used
type-1 metabotropic glutamate receptor (mGluR1) and
adenosine A1 receptor (A1R) as a model of interplaying
GPCRs [13, 14]. In mammalian cerebellar Purkinje neu-
rons, mGluR1 receives the excitatory neurotransmitter
glutamate and activates PKC via the Gq/11 protein-
phospholipase C cascade. This signaling triggers long-
term depression of Purkinje cell’s postsynaptic
glutamate-sensitivity (glu-LTD), a cellular basis for cere-
bellar motor learning [15]. It is shown that mGluR1
forms complexes with A1R [13, 14, 16], which receives
adenosine in the cerebrospinal fluid [17, 18] and acti-
vates Gi/o protein. We have revealed that A1R activation
leads to suppression of glu-LTD [14]. Such inter-GPCR
modulation would be important because it may serve as
the regulatory mechanism of learning behavior. Al-
though circumstantial evidence suggests that ligand-
stimulated A1R attenuates mGluR1 intracellular signal-
ing [14, 19], there was no direct demonstration of the ef-
fect of A1R activation on the activity of mGluR1-
coupled signaling molecule. We assessed the ability of
SPR imaging to detect PKC translocation initiated by lig-
and binding to mGluR1 as well as A1R-mediated modu-
lation of mGluR1-mediated PKC translocation.
Results and discussion
Experimental set-up
HEK293 cell lines could be maintained on the uncoated
gold-plated glass (Fig. 1a,b). Heterologous expression of
the GPCRs could be induced in these cultured cells
within the measurement chamber (see Methods). Such
simple cell handling saved labor and time.
Among the components of the incident light, only one
whose polarization occurs parallel to the plane of inci-
dence (P-polarized light) is consumed to evoke SPR.
Thus, the intensity of the reflection of the P-polarized
light (RP) is sensitive to changes of the SPR curve due to
intracellular protein translocation. On the other hand,
the intensity of the reflection of the component whose
polarization occurs perpendicular to the plane of inci-
dence (S-polarized light; S is the initial of the German
word “senkrecht” standing for perpendicular)(RS) is not
sensitive to the changes of the SPR curve. We quantify
intracellular protein translocation by the ratio of RP to
RS (RP/S) (see Methods for detail).
We measured RP/S, varying the angle of incidence be-
fore and after an application of TPA, a potent PKC acti-
vator (100 nM) (Fig. 1c). In the following analyses, the
angle of incidence was fixed at the value with which
TPA-induced change in RP/S became maximal. In this
study, we once polished the imager’s prism to maintain
the image quality. The angles of incidence for the max-
imal RP/S change were 51.4 ° and 50.3 ° before and after
the polishing, respectively.
Detection of PKC translocation
In non-transfected HEK293T cells, a 25-min application
of the control vehicle {dimethyl sulfoxide (DMSO)}
alone little altered RP/S at the application onset and on-
ward for 25 min. The change of RP/S at the end of the
25-min DMSO application was only +3.8 ± 1.1 % (mean
± SEM; n = 112) of the basal level expressed by the aver-
age over a 5-min period prior to the DMSO application
(Fig. 2a, b). The raw basal RP/S was 57.6 ± 0.8 % and the
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Fig. 2 PKC activation results in an increase in RP/S. (a and b) TPA (100
nM) but not the control vehicle (DMSO) alone increased RP/S in
non-transfected HEK293T cells. In this and following figures, the test
agent-containging saline was dropped into the measurement chamber
after a 5-min basal measurement; the test agent continued to be
present in the chamber onward. a Sample images of the reflection of
the P-polarized light before and after a 25-min application of the
labeled agent. b Mean time-plots of RP/S. Arrow, onset of test agent
application. Error bars, ±SEM. ***, p < 0.0001 at 25 min of the test agent
application onset (van der Waerden rank sum test)
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59.4 ± 0.8 %. In different non-transfected cells of the same
batches of cultures, a 25-min application of TPA (100
nM) increased RP/S by +43.6 ± 1.7 % (n = 127) (Fig. 2a, b).
The raw basal RP/S was 55.0 ± 0.8 % and the raw RP/S at
the end of the 25-min TPA application 77.7 ± 0.7 %. The
extent of RP/S change at the end of the 25-min application
was significantly different between the control vehicle-
and TPA-applied cells (p < 0.0001, Van der Waerden rank
sum test). The polarity of the RP/S change (i.e., increase)
after PKC activation was consistent with the previous re-
port [11].
In non-transfected cells of different batches of cul-
tures, a 25-min application of TPA (100 nM) increased
RP/S by +38.3 ± 2.1 %, (n = 139) (Fig. 3a, b). The raw
basal RP/S was 49.9 ± 1.1 % and the raw RP/S at the end
of the 25-min TPA application 67.0 ± 0.9 %. In different
cells of the same batches of cultures, a 10-min pre-
conditioning with bisindolylmaleimide-1 (BIM1), a PKC
inhibitor, reduced the extent of TPA-induced RP/S in-
crease to +11.7 ± 2.0 % (n = 134) (Fig. 3a, b). The raw
basal RP/S was 45.8 ± 0.8 % and the raw RP/S at the end
of the 25-min TPA application 50.1 ± 0.9 %. The extent
of RP/S change at the end of the 25-min TPA application
was significantly different between the BIM1-untreated
and -treated cells (p < 0.0001, Van der Waerden rank
sum test). These results suggest that the RP/S increase
indeed reports the translocation of activated PKC. In this
study, the cells were not transfected with exogenous
PKC gene. Thus, the RP/S increase was produced by en-
dogenous PKC in HEK293 cells [20].
Expression of A1R and mGluR1 in HEK293am cells
For analysis of mGluR1- and A1R-mediated responses,
we used HEK293am cells, a previously established stable
cell line containing the tetracycline-controlled transcrip-
tional activation system and mGluR1 and A1R genes
[16]. This cell line was designed to express these GPCRs
only when stimulated with a tetracycline derivative such
as doxycycline. We used the inducible expression system
because cell lines expressing the exogenous GPCRs
under the control of constitutive promoters were often
lost [16].
We confirmed the expression of A1R and mGluR1 in
HEK293am cells using immunocytochemistry.
HEK293am cells displayed both immunoreactivities for
A1R and mGluR1 on their surface when stimulated with
doxycycline (Fig. 4, Dox(+)). The absence of immunore-
activities for these GPCRs in doxycycline-untreated cells
(Fig. 4, Dox(-)) suggests that this cell line lacks native
mGluR1 and A1R. This allowed us to focus on the sig-
naling of heterologously expressed GPCRs. Once
expressed in HEK293am cells, A1R and mGluR1 are
thought to form heteromeric complexes as reported in
the previous co-immunoprecipitation and Föster reson-
ance energy transfer studies [14, 16].
a
b
With BIM1, n = 134
Without BIM1, n = 139
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Fig. 3 RP/S increase is due to PKC translocation. a and b The effect
of TPA (100 nM) was examined in non-transfected HEK293T cells
pretreated with saline containing the PKC inhibitor BIM1 (300 nM) or
the control vehicle alone. BIM1 continued to be present in the saline
throughout the measurement. The data were obtained from cultures
different from those in Fig. 2. a Sample images of the reflection of
the P-polarized light. b Mean time-plots of RP/S. Error bars, ±SEM.
***, p < 0.0001 at 25 min of the TPA application onset (van der











Fig. 4 Expression of mGluR1 and A1R in HEK293am cells. Confocal
images of doxycycline-treated or -untreated HEK293am cells
immunostained with anti-A1R and anti-mGluR1 primary antibodies
and fluorescent dye-conjugated secondary antibodies
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Detection of mGluR1-mediated PKC translocation
In doxycycline-treated HEK293am cells, a 25-min appli-
cation of (RS)-3,5-dihydroxyphenylglycine (DHPG), a
group-I mGluR agonist, increased RP/S by +10.6 ± 2.2 %
(n = 158) (Fig. 5a, b). The raw basal RP/S was 55.7 ± 1.1 %
and the raw RP/S at the end of the 25-min DHPG appli-
cation 60.3 ± 1.3 %. This DHPG-induced RP/S increase
was not an artifact because the saline containing the
control vehicle (water) alone did not increase RP/S in
doxycycline-treated HEK293am cells (n = 23, a different
batch of culture; raw basal RP/S, 54.5 ± 1.5 %; raw RP/S at
the end of the 25-min application, 53.2 ± 1.6 %; data not
illustrated). In different doxycycline-treated HEK293am
cells of the same batches of cultures, a 10-min pre-
conditioning with the PKC inhibitor BIM1 abolished the
effect of DHPG (-5.7 ± 1.5 %, n = 184) (Fig. 5a, b). The
raw basal RP/S was 56.3 ± 0.9 % and the raw RP/S at the
end of the 25-min DHPG application 52.9 ± 1.2 %. The
extent of RP/S change at the end of the 25-min DHPG
application was significantly different between the
BIM1-untreated and -treated cells (p < 0.0001, Van der
Waerden rank sum test). These results suggest that SPR
imaging can detect PKC translocation initiated by ligand
binding to mGluR1. In addition, in the presence of
BIM1, RP/S decreased below the basal level (raw value,
56.3 ± 0.9 %) at the late phase of the measurement (56.1
± 1.1 to 52.9 ± 1.2 % at 15–25 min of the DHPG applica-
tion onset). A possibility is that BIM1 not only ham-
pered DHPG-induced PKC activation but also
attenuated the basal activity of PKC as previously shown
in HEK293 cells (e.g., ref. [21]).
In doxycycline-treated HEK293am cells of different
batches of culture, the relative extent of DHPG-induced
RP/S increase changed in a DHPG-dose dependent man-
ner (Fig. 5c, d), suggesting that SPR imaging can be used
for quantitative evaluation of GPCR signaling. The
microscopic dissociation constant and Hill coefficient es-
timated from the Hill equation fitted to the dose-
response data were 12.8 μM and 0.51, respectively
(Fig. 5d). It is noteworthy that desensitization was evi-
dent with the highest dose (5 mM) of DHPG (Fig. 5c).
This might be due partly to the kinetic property of
mGluR1 because desensitization is observed commonly
for mGluR1-mediated cation channel current and
Before DHPG After DHPGa
b
With BIM1, n = 184





















































Fig. 5 SPR imaging can detect PKC translocation initiated by ligand
binding to mGluR1. a and b In doxycycline-treated HEK293am cells,
the mGluR1 agonist DHPG (50 μM) increased RP/S and this effect of
DHPG was abolished with a 10-min pre-conditioning with the PKC
inhibitor BIM1 (300 nM). BIM1 continued to be present in the saline
throughout the measurement. a Sample images of the reflection of
the P-polarized light. b Mean time-plots of RP/S. Error bars, ±SEM. ***,
p < 0.0001 at 25 min of the DHPG application onset (van der Waerden
rank sum test). c and d Dose-dependence of DHPG-induced RP/S
increase. c Sample mean response of HEK293am cells to serial
applications of a test dose (50 μM) and a reference dose (5 mM) of
DHPG. On such a mean time-plot, the extents of quasi-maximal RP/S
increases with the test and reference doses (a and b, respectively) were
measured. d Dose-response relation depicted using the ratio a/b. Each
dot indicates the data obtained from the mean response of 17-42 ROIs.
Sigmoid curve, Hill function fitted to the data
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intracellular Ca2+ mobilization induced by high doses of
DHPG in cerebellar neurons [22].
It is reported that doxycycline may inhibit multiple
intracellular signaling pathways [23]. Thus, replacement
with the doxyclycline-containing culture medium with
the doxycycline-free saline before the measurement
could possibly relieve the cells from such doxycycline-
induced inhibition during the measurement. This alone
or together with DHPG stimulation could produce a
pseudo response. However, non-transfected HEK293T
cells treated with doxycycline (2 μg/ml, 32 h) prior to
the measurement did not display a RP/S increase in re-
sponse to DHPG (50 μM) (n = 25; raw basal RP/S, 53.7 ±
1.1 %; raw RP/S at the end of the 25-min DHPG applica-
tion, 52.8 ± 1.2 %; data not illustrated). This result sug-
gests that the DHPG-induced RP/S increases observed in
the HEK293am cells (Figs. 5 and 6) were indeed
mGluR1-mediated responses but not the pseudo
responses.
Detection of modulation of mGluR1-mediated PKC trans-
location by A1R
In doxycycline-treated HEK293am cells of different
batches of cultures, a 25-min application of DHPG again
increased RP/S by +10.7 ± 1.4 % (n = 211) (Fig. 6a,b). The
raw basal RP/S was 58.9 ± 0.8 % and the raw RP/S at the
end of the 25-min DHPG application 64.5 ± 1.0 %. In
different doxycycline-treated cells of the same batches of
cultures, a 10-min pre-conditioning with (R)-N6-phenyli-
sopropyladenosine (R-PIA), an A1R-selective agonist,
abolished DHPG-induced RP/S increase (-1.3 ± 1.1 %, n =
229) (Fig. 6a, b). The raw basal RP/S was 57.0 ± 0.8 % and
the raw RP/S at the end of the 25-min DHPG application
56.5 ± 1.0 %. The extent of RP/S change at the end of the
25-min DHPG application was significantly different be-
tween the R-PIA-untreated and -treated cells (p < 0.0001,
Van der Waerden rank sum test). This result suggests
that A1R activation leads to suppression of mGluR1-
PKC signaling.
PKC is an essential mediator for induction of cerebel-
lar LTD. PKC-mediated phosphorylation is thought to
trigger endocytosis of ionotropic glutamate receptor, the
final stage of cererellar LTD induction [15]. Thus, the
previously reported negative effect of A1R agonist on
glu-LTD [14] can be ascribed at least in part to suppres-
sion of mGluR1-mediated PKC activation by A1R (Fig. 6).
Moreover, we observed this suppression in the non-
neuronal cells, suggesting that A1R-mGluR1 functional
interplay may occur independently of the neuron-
specific cellular environment.
We confirmed that A1R indeed mediated the effect of
R-PIA, using a HEK293 cell line that expressed mGluR1
and Gq/11 protein-coupled gastrin-releasing peptide re-
ceptor (GRPR) but not A1R (HEK293gm cells).
Although pre-conditioned with a high dose (5 μM) of R-
PIA for 10 min, doxycycline-treated HEK293gm cells
displayed a RP/S increase in response to DHPG (50 μM).
The extent of this increase (at the end of the 25-min
DHPG application, +15.9 ± 1.0 %, n = 143) was compar-
able with that of the HEK293am cells (Fig. 6b). The raw
basal RP/S was 70.3 ± 0.9 % and the raw RP/S at the end
of the 25-min DHPG agent application 80.4 ± 0.7 %.
Reproducibility and stability of measurement
The extent of TPA-induced RP/S increase was similar be-
tween the different batches of cultures (~50 % at 25 min
of the application onset, Figs. 2b vs. 3b). As well, the ex-
tent of DHPG-induced RP/S increase was similar between
the different batches of cultures (for 50 μM, ~10 % at



















With R-PIA (n = 229)
With R-PIA (n = 143)
Without R-PIA (n = 211)
Fig. 6 A1R activation leads to suppression of mGluR1-mediated PKC
activation. a and b In doxycycline-treated HEK293am cells, a 25-min
application of DHPG (50 μM) increased RP/S. A 10-min pre-
conditioning with the A1R antagonist R-PIA (500 nM) abolished the
DHPG (50 μM)-induced RP/S increase. R-PIA continued to be present
in the saline throughout the measurement. The data were obtained
from cultures different from those in Fig. 5. a Sample images of the
reflection of the P-polarized light. b Mean time-plots of RP/S. Error
bars, ±SEM. ***, p < 0.0001 at 25 min of the DHPG application onset
(van der Waerden rank sum test). Plot with gray triangles, the
response of the HEK293gm cells treated with doxycycline and
pre-conditioned with R-PIA (5 μM)
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25 min of the application onset, Figs. 5b vs. 6b). These re-
sults indicate the high reproducibility of the measurement.
The control vehicle did not change RP/S at the application
onset and onward for 25 min (Fig. 2b), indicating that the
measurement is robust against physical shock due to test
drug application and can stably monitor the response of
living cells for a long time. With the easiness-to-use and
reliability, SPR imaging in heterologous expression cell
preparations may provide a useful experimental paradigm
for investigation of GPCR signaling.
Conclusions
In HEK293 cell lines, SPR imaging could detect PKC
translocation resulting from direct activation of PKC it-
self or initiated by ligand binding to heterologously
expressed mGluR1. SPR imaging could also detect the
modulation of heterologously expressed mGluR1-
mediated PKC translocation by heterologously expressed
A1R. SPR imaging in heterologous expression cells pro-
vides a powerful yet easy-to-use tool for analyzing
GPCR-coupled intracellular signaling and inter-GPCR
modulation in living cells.
Methods
Cell preparation
HEK293 cell lines were passaged every 3 or 4 days. The
cells were detached from the old dish (diameter, 60 mm;
353002, Falcon, Becton, Dickinson and Company, Frank-
lin Lakes, NJ, USA) by sequential treatments with ethyl-
enediaminetetraacetic acid (0.22 w/v %)–containing
phosphate-buffered saline (PBS) and a trypsin solution
(TrypLE Express, 12605-010, Life Technologies). The de-
tached cells were suspended in a Dulbecco’s modified
Eagle medium (08458-45, Nacalai Tesque, Kyoto, Japan)
containing 10 v/v % fetal bovine serum (FBS)(12483-012,
Life Technologies), 100 units/ml penicillin G potassium
(26239-42, Nacalai Tesque), and 100 μg/ml streptomycin
sulfate (32204-92, Nacalai Tesque). The cell suspension
was poured into a new dish containing the same medium,
and the cells were maintained at a temperature of 37 °C, a
CO2 concentration of 5 %, and a humidity of 96 %.
For analysis of mGluR1- and A1R-mediated responses,
we used HEK293am cells, a previously established stable
cell line containing the tetracycline-controlled transcrip-
tional activation system and mGluR1 and A1R genes [16].
This cell line expressed these receptors only when stimu-
lated with a tetracycline derivative such as doxycycline.
We used the inducible expression system because cell
lines expressing the exogenous GPCRs under the control
of constitutive promoters were often lost [16]. For selec-
tion of HEK293am cells, the medium was supplemented
with 15 μg/ml blasticidin S hydrochloride (KK-400, Kaken
Pharmaceutical, Tokyo, Japan), 120 μg/ml hygromycin B
(09287-84, Nacalai Tesque), and 480 μg/ml G418 (09380-
44, Nacalai Tesque). For negative control, we used
HEK293gm cells, a newly created stable cell line contain-
ing the tetracycline-controlled transcriptional activation
system and mGluR1 and GRPR genes. We maintained the
HEK293gm cells as in the case of the HEK293am cells.
For SPR imaging, 500 μl of the cell suspension was pre-
pared as above and placed in a chamber that was con-
structed with a silicone rubber wall (volume, 0.88 ml;
032039, flexi PERM, Greiner Bio-One, Kremsmünster,
Austria) attached to a 50 nm-thick gold-plated slide glass
(012190, BAS, Tokyo, Japan) 2 days prior to the measure-
ment and cultured until the measurement. To induce gene
expression in HEK293am or HEK293gm cells, the old
medium was replaced with the fresh medium supple-
mented with 2 μg/ml doxycycline (324385, Calbiochem,
La Jolla, CA, USA) 1 day prior to the measurement. The
individual cells were used for only one measurement ses-
sion. To minimize possible influence of passage-to-
passage or batch-to-batch deviation in cell responsiveness,
the data were compared within cultures of the same pas-
sage generation of the same batch.
Immunocytochemistry
HEK293am cells cultured in a glass-based dish were
treated with doxycycline for 16 h as above. The cells
were fixed at 4 °C for 30 min with 0.1 M sodium phos-
phate buffer containing 4 w/v % paraformaldehyde. The
fixed cells were rinsed with PBS and then incubated at
room temperature for 30 min in PBS containing 0.1 v/
v % Triton X-100 and 5 v/v % FBS. The cells were then
probed at 4 °C overnight with 1 μg/ml primary anti-
bodies against mGluR1 and A1R (mouse anti-mGluR1
antibody, 610965, BD Bioscience, San Jose, CA, USA; in-
house rabbit antibody against amino acids 309–329 of
rat A1R [14]), and subsequently stained at room
temperature for 2.5 h with 5 μg/ml fluorescent dye-
conjugated secondary antibodies (Alexa Fluors 448 and
594, Molecular Probes, Eugene, OR, USA). Cell images
were captured using a confocal laser microscope (SP5/
TCS, Leica Microsystems, Wetzlar, Germany).
SPR imaging
We performed two-dimensional SPR imaging according to
refs. [10, 11]. Briefly, the cell chamber was rinsed three
times with saline consisting of (in mM): 147 NaCl, 3 KCl, 2
CaCl2, 1 MgCl2, 10 HEPES, and 10 D-glucose (pH adjusted
to 7.4 with NaOH) and then filled with 270 μl of the saline.
The chamber was placed on a SPR imager (2D-SPR04B,
NTT Advanced Technology, Kawasaki, Kanagawa, Japan)
with matching oil (refractive index, 1.8000; 12787, Cargille
Laboratories, Cedar Grove, NJ, USA). Imaging was
performed at a room temperature of ~25 °C. The bot-
tom of the chamber was illuminated with 770-nm in-
cident light (light source output current, 50 mA) at a
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fixed angle of incidence. The image of the reflection
from the specimen was captured using the charge-
coupled device camera built in the imager (objective
lens magnification, x7; cooling temperature, 0 °C).
Each image frame had a size of 639 x 479 pixels and
a gray scale of 12 bits and was stored in bmp format.
We sequentially captured the images of RP with an ex-
posure time per frame of 1 or 5 s and an interval of 10
or 50 s (test session). For reference, we captured the im-
ages of RS immediately before and after the test session
(reference sessions).
Drug preparation and application
TPA (4174S, Cell Signaling Technology, Danver, MA,
USA) was dissolved in DMSO (13407-45, Nacalai Tesque)
to a concentration of 2 μM and kept at -50 °C until use.
BIM1 (203291, Calbiochem) was dissolved with water to a
concentration of 300 μM and kept at 4 °C until use.
DHPG (0342, Tocris Cookson, Bristol, UK) was dissolved
in water to a concentration of 5 mM and kept at -50 °C
until use. R-PIA (P4532, Sigma-Aldrich, St. Louis, MI,
USA) was dissolved into water to a concentration of
500 μM and kept at 4 °C until use. On the day of experi-
ment, the stock solution of the test drug was diluted into
the saline to a concentration 10 times higher than the final
concentration. An application was done by dropping 30 μl
of the drug-containing saline to the cell chamber.
Data analysis
The reflection intensity was analyzed using ImageJ 64 bit
software (National Institute of Health, Bethesda, MD,
USA) or the dedicated analyzing software supplied by the
manufacturer of the SPR imager. A group of tightly gath-
ered cells was selected as a single region of interest (ROI).
A ROI was an ellipse typically with 50–200 pixels (~3–
12 μm2). Mean RP over each ROI was calculated for each
image frame of the test session. Mean RS over the ROI
was calculated for each image frame of the reference ses-
sions and averaged over these sessions. To evaluate the ex-
tent of change, RP was normalized to the averaged RS for
each ROI (raw RP/S) and then further %-normalized, tak-
ing the mean over a 5-min period prior to the test agent
application as 100 % for each ROI.
To measure the dose-response relation of the DHPG-
induced RP/S increase, we first applied a test dose (5–
500 μM) of DHPG and then applied the reference dose
(5 mM) of DHPG to the same cells. For each ROI, the
mean extent of the quasi-maximal RP/S increase with a
test dose was expressed relative to that with the
reference dose. In the cases of the test doses, the extent
was measured at 17 min of the DHPG application onset.
In the case of the reference dose, the extent was
measured at the peak of response because there was
evident desensitization. A Hill equation in a form of
R ¼ L½ nHKDð ÞnHþ L½ nH , where R, L, KD, and nH, were the relative
extent of response, DHPG dose, microscopic dissociation
constant, and Hill coefficient, respectively, was fitted to
the data plotted in Fig. 5d using Excel 2008 software
(Microsoft, Redmond, WA, USA) with Solver plug-in.
Each group of numerical data is expressed as mean ±
SEM. A difference between a pair of the data groups was
examined with a non-parametric statistical test (van der
Waerden rank sum test) using JMP 9 software (SAS,
Cary, NC, USA) because the original distribution of the
data might be distorted through %-normalization.
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